{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"20"}],"units":"Participants"}],"description":"Number of patients who experienced graft rejection by Day 100","groups":[{"description":"Patients receiving Fludarabine, Busulfan, cyclophosphamide and post-transplant cyclophosphamide for a haploidentical donor transplant","id":"OG000","title":"Haploidentical Transplant"}],"paramType":"NUMBER","populationDescription":"20 patients were treated and able to be analyzed for graft rejection","reportingStatus":"POSTED","timeFrame":"Day 100","title":"Incidence of Graft Rejection for Patients at Day 100","type":"PRIMARY","unitOfMeasure":"participants"}